Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 635
Recruiting: 365
Ph III recruiting: 20
Growth YoY: −15.2%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (367)

clinicaltrialsPublishedShowing 301–350 of 2,688 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06625190	Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors	recruiting	Phase 1 / Phase 2	27	University of FloridaOTHER	1	Jun 30, 2026	clinicaltrials
NCT07675967	Clonal Hematopoiesis Chemotherapy and Radiation Effects Study(CH CARE)	recruiting	—	5,000	Dana-Farber Cancer InstituteOTHER	1	Jun 30, 2026	clinicaltrials